Royal Bank of Canada
LHDX

Royal Bank of Canada’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Royal Bank of Canada’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,660
Closed -$1K – 7783
2022
Q4 		$1K Sell
11,660
-144
-1% -$92 ﹤0.01% 7144
2022
Q3 		$12K Buy
11,804
+144
+1% +$328 ﹤0.01% 6368
2022
Q2 		$22K Hold
11,660
– – ﹤0.01% 6080
2022
Q1 		$42K Hold
11,660
– – ﹤0.01% 6207
2021
Q4 		$100K Hold
11,660
– – ﹤0.01% 5945
2021
Q3 		$89K Buy
11,660
+10,999
+1,664% +$92.8K ﹤0.01% 5793
2021
Q2 		$4K Sell
661
-341
-34% -$2.15K ﹤0.01% 7151
2021
Q1 		$12K Buy
+1,002
New +$19.9K ﹤0.01% 6733

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return